Sensitivity of T-wave morphology and the QT interval to small drug-induced electrocardiographic changes

The electrocardiographic QT interval is the only widely used surrogate marker of repolarization abnormality in drug trials. However, numerous basic and clinical studies have provided evidence that disturbed ventricular repolarization is reflected not only in the duration of the QT interval but also in the shape of the electrocardiographic T-wave. Thus, in order to elucidate the full spectrum of drug-induced repolarization changes, it is pertinent to perform a thorough analysis of T-wave morphology changes in addition to measuring the QT interval. We present a computerized method for quantification of drug-induced T-wave morphology changes. Our results provide evidence that the shape of the T-wave can be a more sensitive marker of disturbed repolarization than QT interval prolongation. Effect sizes for T-wave morphology changes, 1.58plusmn0.30 (meanplusmnSD) were 1.8 times larger than those for QTcF, 0.87plusmn0.14, p=0.0013.

[1]  Johannes J. Struijk,et al.  Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology , 2006, Computers in Cardiology, 2005.

[2]  G. Kay,et al.  Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. , 1983, Journal of the American College of Cardiology.

[3]  L. Demay,et al.  Notched T Waves on Holter Recordings Enhance Detection of Patients With LQT2 (HERG) Mutations , 2001, Circulation.

[4]  S. Swiryn,et al.  Torsade de pointes due to quinidine: observations in 31 patients. , 1984, American heart journal.

[5]  Wojciech Zareba,et al.  Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval. , 2006, Heart rhythm.

[6]  Michael Christiansen,et al.  T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. , 2004, Heart rhythm.

[7]  C Antzelevitch,et al.  The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. , 2000, European heart journal.

[8]  Marek Malik,et al.  The Imprecision in Heart Rate Correction May Lead to Artificial Observations of Drug Induced QT Interval Changes , 2002, Pacing and clinical electrophysiology : PACE.

[9]  David Zeltser,et al.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[10]  M. P. Andersen,et al.  A robust method for quantification of IKr-related T-wave morphology abnormalities , 2007, 2007 Computers in Cardiology.

[11]  M. Malik,et al.  Variability of heart rate correction methods for the QT interval. , 2003, British journal of clinical pharmacology.

[12]  Jeffrey B. Gross,et al.  Timing of New Black Box Warnings and Withdrawals for Prescription Medications , 2003 .